Name: | HanWeidong |
Post: | Research Associate |
Position: | |
Education: | Ph.D. |
Professional: | oncology |
Departments: | The Affiliated Sir Run Run Shaw Hospital |
Research: | Role of Autophagy in Cancer |
TEL: | 13819124503 |
E-mail: | hanweidong1979@gmail.com |
Personal Home Page: | |
Profile
PROFESSIONAL EXPERIENCE
12/2011-now: Research Associate, Specialist in medical oncology, Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, China
5/2011-10/2012: Postdoctoral fellow, City of Hope National Medical Center, Duarte, CA, USA
6/2010-4/2011: Specialist in medical oncology, Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, China
8/2008-6/2010: Physician resident, Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, China
EDUCATION
9/2003-6/2008: Doctor of medicine,Zhejiang University College of Medicine, Hangzhou, China
9/1998-6/2003: Bachelor of medicine,Zhejiang University College of Medicine, Hangzhou, China
AWARDS and HONORS
Kun Shan-Zong Renqing memorial hospital scholarship at Zhejiang University, 2005-2006
Chu-Kezhen Scholarship (the highest scholarship) at Zhejiang University, 2006-2007
Honour of Excellent Graduate of Zhejiang Province, China, 2008
National Excellent Doctoral Dissertation Award nomination, China, 2010
PUBLICATIONS
1. Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo J, Hu X. Shikonin circumvents cancer multidrug resisatnce by induction of necroptosis. Molecular Cancer Therapeutics. 2007;6(5);1641- 1649. IF: 5.226.
2. Li L, Han W*, Gu Y, Qiu S, Lu Q, Jin J, Luo J, Hu X. Honokiol induces a necrotic cell death through mitochondrial permeability transition pore. Cancer Research. 2007;67 (10);4894-4903. *co-first author. IF: 7.856
3. Hu X, Han W, Li L. Targeting the Weak Point of Cancer by Induction of Necroptosis. Autophagy. 2007;3(5);490-492. IF: 7.453
4. Zhang K, Han W*, Zhang R, Xu X, Pan Q, Hu X. Phenylobacterium zucineum sp. nov., a facultative intracellular bacterium isolated from a human erythroleukemia cell line K562. Systematic and applied microbiology. 2007;30(3);207-212. *co-first author. IF: 3.366
5. Li L, Pan Q, Han W, Liu Z, Li L, Hu X. Schisandrin B Prevents Doxorubicin-induced Cardiotoxicity via Enhancing Glutathione Redox Cycling. Clinical Cancer Research. 2007; 13(22):6753-6760. IF: 7.742
6. Han W, Xie J, LI L, Liu z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis. 2009,May,01;14(5):674-86. IF: 4.788
7.Han W, Pan H, Chen Y, Sun J, Wang Y, et al. EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells. PLoS ONE 2011 6(6): e18691. doi:10.1371/journal.pone.0018691. IF: 4.092
8. Han W, Sun J, Feng L, Wang K, Li D, et al. Autophagy Inhibition Enhances Daunorubicin- Induced Apoptosis in K562 Cells. PLoS ONE 2011 6(12): e28491. doi:10.1371/journal. pone. 0028491. IF: 4.092
9. Wang Y, Ding L, Wang X, Zhang J, Han W, Feng L, Sun J, Jin H, Wang XJ. Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells. Am J Transl Res. 2012;4(1):44-51. Epub 2012 Jan 5.
10.Han, W.; Xie, J.; Fang, Y.; Wang, Z.; Pan, H. Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2. Int. J. Mol. Sci. 2012, 13, 7212-7225. IF: 2.598